Immediate Impact
6 from Science/Nature 36 standout
Citing Papers
Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
2023 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue
2023 Standout
Works of Nancy Carpenter being referenced
Long-term follow-up for up to 5 years on the risk of leukaemic progression in thrombocytopenic patients with lower-risk myelodysplastic syndromes treated with romiplostim or placebo in a randomised double-blind trial
2018
Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Nancy Carpenter | 261 | 76 | 29 | 75 | 18 | 395 | |
| Nisha Jain | 275 | 61 | 8 | 42 | 27 | 452 | |
| R. M. van Soesbergen | 218 | 21 | 4 | 33 | 20 | 442 | |
| Milka M. Montiel | 77 | 28 | 7 | 25 | 17 | 388 | |
| F. Lelong | 118 | 38 | 19 | 28 | 20 | 455 | |
| Mahmoud Al-Sheyyab | 40 | 57 | 41 | 48 | 20 | 384 | |
| Oya Levendoglu‐Tugal | 171 | 37 | 22 | 24 | 24 | 341 | |
| Stefania Tamiazzo | 50 | 28 | 29 | 15 | 13 | 384 | |
| Aline Naumann | 48 | 41 | 4 | 11 | 15 | 369 | |
| Sorrell L. Wolfson | 67 | 80 | 3 | 30 | 14 | 341 | |
| Kristen Hayward | 198 | 40 | 4 | 40 | 17 | 390 |
All Works
Loading papers...